knowledge -WSS

knowledge

author：hotspot 2025-09-28 01:37:47 - browse：6651

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

focus

hotspot

WSS

Free medical tuition alone isn't enough to close gaps in primary care

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Obesity drug from Roche shows promise in early study

Medical mystery: When a cough is not just a cough

How digital tools helped lower hypertension in marginalized patients

Supreme Court to hear if Covid misinformation is protected speech

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

The United States must get value

23andMe had bad news about my health. I wish a person had delivered it

Biden report: The neurospychology of memory and aging

Medicare proposal to cover medical devices draws a mixed reaction

Doctors' information doesn't help them choose wisely when sick

Wildfire smoke exposes gaps in outdoor worker protections

What should King Charles tell the public about his cancer?

How to save PrEP access — and even expand it

Abbott's new stent may help patients with peripheral artery disease

hotspot

Lilly’s weekly insulin works as well as daily products, new studies show

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Vaccine advisory panel ACIP left half staffed by HHS

How digital tools helped lower hypertension in marginalized patients

Doctors' information doesn't help them choose wisely when sick

The Readout: Gilead, Bernie Sanders, and other pharma news

focus

hotspot

hotspot

hotspot